About Ehave Inc.
Ehave (OTC: EHVVF) is a prominent healthcare services and technology enterprise that prioritizes advancing Psychedelics-to-Therapeutics through the development of innovative compounds and treatment approaches for the enhancement of brain health.
Collaborating with a team of experts in the fields of science and mental health, they strive to generate reliable and efficient therapeutics that cater to a diverse range of mental health concerns. Ehave utilizes clinical data to optimize patient outcomes and remain steadfast in their mission to create a safe and effective treatment for patients.
For more information, please visit https://www.ehave.com/
Investor Media is social media marketing firm that assists companies in over branding and content creation, and as such is retained by clients for developing digital content and marketing services.
Nothing on this site, or supported documents, should constitute a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Investcore Media (“Investcore”) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. Investcore, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Investcore was not compensated for this company profile. Investcore, or its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
High Risk: Small and Micro cap, or ‘penny stocks’, involve a high degree of risk, and we highly encourage investors to consult with a financial advisor before making any and all investment decisions when investing in these type of securities.